Artificial Intelligence (AI) in Biotechnology Market Size, Share, By Offering (Hardware, and Software & Services), By Application (Health Informatics, Therapeutic Development, Epidemiological Modeling, Remote monitoring & Wearable, and Others), By Usage (Forensic Biotechnology, Clinical Biotechnology, Environmental Monitoring, and Others), and Region - Trends, Analysis and Forecast till 2034

By Region, the Artificial Intelligence (AI) in Biotechnology Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. 

This region, particularly the United States, leads in AI adoption in biotechnology due to its strong presence of biotech companies, advanced AI infrastructure, and significant investment in research and development. The region benefits from a robust healthcare system, a large number of AI-driven startups, and government support for technological innovation.

Another major dominating region is Europe, where the UK, Germany, and France are at the forefront of biotechnology-related AI research. Through a number of programs and frameworks, the European Union has been aggressively investing in biotechnology and AI, with a focus on the ethical application of AI and its integration with agricultural and healthcare biotech. Numerous leading biotech companies that use AI for genomics, personalized medicine, and drug development are also based in the area.